NARA Discovery
Article Details
← Back to Search Results
Journal Article

Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation

Marjo J. Karjalainen; Pertti J. Neuvonen; Janne T. Backman
European Journal of Clinical Pharmacology · Vol. 63, Issue 9 · pp. 829-836 · 2007
View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

JournalEuropean Journal of Clinical Pharmacology
PublisherSpringer
Publication Date2007-08-08
Publication Year2007
Volume63
Issue9
Pages829-836
Document TypeJournal Article
Print ISSN0031-6970
eISSN1432-1041
DOI10.1007/s00228-007-0335-z

Access Information

NARA Access Coverage1968-01-01~Current
Journal Homepagehttps://www.springer.com/journal/228
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.